Core Viewpoint - Dabo Medical (002901) experienced a stock price decline of 3.77% to 49.2 yuan as of February 2, 2026, with a total market capitalization of 20.37 billion yuan [1]. Group 1: Stock Performance - The stock opened at 51.31 yuan, reached a high of 51.31 yuan, and a low of 49.15 yuan on the same day [1]. - The trading volume was 1.43 million yuan, with a turnover rate of 0.99% [1]. Group 2: Shareholder Meeting - Dabo Medical held its first extraordinary general meeting of shareholders for 2026 on February 2, 2026, using a combination of on-site voting and online voting [1]. - A total of 32 shareholders and their proxies attended the meeting, representing 348,862,370 shares with voting rights, accounting for 85.3454% of the total voting shares [1]. Group 3: Board Elections - The meeting approved the election of independent directors and non-independent directors for the fourth board of directors [1]. - The elected independent directors are Xiao Wei, Wei Zhi Hua, and Fan Wei Wei, while Lin Zhi Xiong, Lin Zhi Jun, and Wang Shu Lin were elected as non-independent directors [1]. - The term for the fourth board of directors is three years, starting from the date of approval by the shareholders' meeting [1].
大博医疗(002901)披露2026年第一次临时股东会决议公告,2月2日股价下跌3.77%